Dr. Noubar Afeyan
Dr. Noubar Afeyan is founder and CEO of Flagship Pioneering, a company that conceives,
creates, resources, and develops first-in-category bioplatform companies to
transform human health and sustainability. An entrepreneur and biochemical engineer, Dr.
Afeyan holds more than 100 patents and has co-founded and helped build more than 70 life
science and technology startups during his 33-year career. He is co-founder and chairman of
the board of Moderna, the pioneering messenger RNA vaccine company addressing the
global COVID-19 pandemic, and serves on the boards of several private and public
A fervent believer that entrepreneurship involves skills and practices that can be
professionalized and taught, Dr. Afeyan has been a Lecturer at Harvard Business School and
Senior Lecturer at MIT where he taught technology-entrepreneurship and innovation for
more than two decades. He received a Technology Pioneer 2012 award from the World
Economic Forum (WEF), was awarded the National Order of Merit from his native Lebanon
in 2021, a Great Immigrant honor from the Carnegie Corporation in 2016, and the Ellis
Island Medal of Honor in 2008.
Dr. Afeyan is a member of the Corporation of MIT (the Institute’s governing body) and a
member of the board of trustees for the Boston Symphony Orchestra. Together with his
partners, Noubar has launched and supported philanthropic projects including the IDeA
Foundation, UWC Dilijan School, FAST, and the Aurora Prize for Awakening Humanity to
raise awareness of the world’s most pressing humanitarian problems. Previously, he was a
co-founder and board member of the National Competitiveness Foundation of Armenia, a
private-public partnership dedicated to promoting economic development in the former
Soviet Republic of Armenia.
A passionate advocate of the contributions of immigrants to economic and scientific progress,
Dr. Afeyan received the Appeal of Conscience Award in 2020 and the Golden Door Award in
2017 from the International Institute of New England, in honor of his outstanding
contributions to American society as a U.S citizen of foreign birth.